Correlative Studies
Imaging-guided biopsies were performed before and after 2 weeks of ulixertinib lead-in for patients in dose de-escalation phase. Biopsied samples were subjected to formalin-fixation and paraffin-embedment for immunohistochemistry and snap-frozen for RNA-Seq.